Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (182)	1/9/2003 3:42:19 PM
From: Jibacoa	Respond to of 3722

ILMN Has been up 14.2% on volume of 27,266 (albeit the last trade of 200 shares caused a downtick.<g>) ILMN announced today an agreement with Genome Quebec for the purchase of its SNP genotyping solution which includes all aspects of a production-scale laboratory and will be an integral component of the new Genome Quebec Innovation Centre, at McGill University. siliconinvestor.com The stock had a good drop from its Nov.15 H (5.94)to its Dec.7 L (2.62)and needs to close above its Dec.20 H of 3.89 siliconinvestor.com Bernard